U.S. Banks Stock News

Columbus McKinnon (CMCO) has put fresh numbers on the table for Q3 2026, with recent quarterly revenue figures ranging from about US$234 million to US$261 million and basic EPS moving between a loss of US$0.52 and a gain of US$0.16 over the past six reported quarters. Over that same stretch, total revenue has oscillated within a relatively tight band of roughly US$234 million to US$262 million per quarter while EPS has swung from losses to modest profits, setting up a mixed picture that puts...

Bloom Energy (BE) FY 2025 earnings snapshot Bloom Energy (BE) has wrapped up FY 2025 with fourth quarter revenue of US$777.7 million and basic EPS of roughly US$0.00, alongside net income excluding extra items of US$1.1 million. The company has seen revenue move from US$572.4 million and basic EPS of US$0.46 in Q4 2024 to US$777.7 million and roughly flat EPS in Q4 2025. Trailing twelve month revenue now sits at about US$2.0 billion against a loss of US$88.4 million, setting up a results...

If you are wondering whether Arthur J. Gallagher's current share price still makes sense after a strong multi year run, this article will walk you through how its value stacks up against key benchmarks. The stock last closed at US$205.31, with returns of 17.7% decline over 7 days, 22.5% decline over 30 days, 19.8% decline year to date, 36.2% decline over 1 year, 10.9% over 3 years and 84.0% over 5 years. These moves may signal a shift in how the market is pricing the business. Recent...

How BorgWarner’s Latest Earnings Set the Stage for the Story Ahead BorgWarner (BWA) just posted third quarter FY 2025 results with revenue of US$3,591 million and basic EPS of US$0.74, giving investors a fresh read on how its auto components business is tracking through the year. Over recent periods, revenue has moved from US$3,439 million in Q4 2024 to US$3,515 million in Q1 2025 and US$3,638 million in Q2 2025, while basic EPS has shifted from a loss of US$1.84 in Q4 2024 to US$0.72,...

Penske Automotive Group (PAG) just posted third quarter FY 2025 results with revenue of about US$7.7b and basic EPS of US$3.23, alongside net income of US$213m. Trailing 12 month EPS sits at US$14.20 on revenue of roughly US$30.7b and net income of US$943.7m. Over recent quarters the company has seen revenue move in a tight band from US$7.6b to US$7.7b, with quarterly basic EPS ranging between US$3.23 and US$3.78. This sets up a picture where modest earnings growth and a 3.1% net margin put...

Zillow Group (ZG) just wrapped up FY 2025 with Q4 revenue of US$654 million and basic EPS of US$0.01, alongside trailing twelve month revenue of US$2.6 billion and EPS of US$0.10, marking a clean shift into positive earnings territory over the past year. The company has seen quarterly revenue move from US$554 million and a basic EPS loss of US$0.22 in Q4 2024 to US$654 million and EPS of US$0.01 in Q4 2025, while trailing twelve month EPS moved from a loss of US$0.48 to a profit of US$0.10...

Conference spotlight and recent stock performance Enovis (ENOV) is set to present at the Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, Utah on February 11, 2026, drawing fresh attention to the stock. The appearance follows a challenging 2025 in which the share price declined about 50% over the past year. The stock has also faced pressure in recent months, with returns of 15% over the past month and 26% over the past 3 months. See our latest analysis...

Why Gentex’s latest earnings and guidance matter for shareholders Gentex (GNTX) shares have been reacting to a cluster of fresh information, including higher fourth quarter sales and net income, new revenue guidance for 2026 and 2027, and completion of a recent buyback tranche. See our latest analysis for Gentex. Gentex’s latest earnings beat and new 2026 to 2027 revenue guidance come after a 4.9% 90 day share price return and a 5 year total shareholder return of 25.4% decline. This suggests...

BlackLine (BL) has wrapped up FY 2025 with fourth quarter revenue of US$183.2 million and basic EPS of US$0.08, alongside net income of US$4.9 million. Over recent quarters the company has seen revenue move from US$169.5 million in Q4 2024 to US$183.2 million in Q4 2025, while quarterly basic EPS shifted from US$0.90 to US$0.08. This sets the backdrop for a year where margins are front and center for investors. See our full analysis for BlackLine. With the latest numbers on the table, the...

Artisan Partners Asset Management (APAM) has drawn fresh attention after reporting fourth quarter and full year 2025 results, as well as declaring a combined US$1.58 per share dividend that includes a special payout. See our latest analysis for Artisan Partners Asset Management. Against this backdrop, Artisan Partners Asset Management’s share price closed at US$44.27, with a 1-day share price return of a 2.51% decline, a 6.91% year to date share price return, and a 3-year total shareholder...

Upstart Holdings (UPST) has closed out FY 2025 with Q4 revenue of US$304.2 million and basic EPS of US$0.19, rounding off a trailing twelve month profile that includes US$1.1 billion in revenue and EPS of US$0.56 as the company moved into positive earnings territory over the year. The company has seen quarterly revenue move from US$220.4 million in Q1 2025 to US$304.2 million in Q4, while basic EPS tracked from a loss of US$0.03 in Q1 to profits of US$0.06, US$0.33 and then US$0.19 in Q2, Q3...

In recent months, several analysts have updated their views on Acushnet Holdings, offering a range of positive and cautious ratings based on company performance and market conditions. Their reassessments highlight how shifting expectations around golf participation, margins, and brand strength are shaping the outlook for this premium golf equipment and apparel provider. We’ll now examine how these analyst upgrades and growing confidence in Acushnet’s outlook influence the company’s broader...

SFL (NYSE:SFL) has just posted its FY 2025 third quarter numbers, with revenue of US$175.2 million and EPS of US$0.07. This sets a fresh datapoint for a year that has swung from a loss per share of US$0.24 in Q1 to a small profit in Q2 and Q3. The company has seen quarterly revenue move from US$188.6 million in Q2 2024 to US$253.2 million in Q3 2024, and then settle in a range between US$175.2 million and US$188.5 million across the first three quarters of 2025. EPS has shifted from US$0.34...

Seagate Technology Holdings filed a large shelf registration, covering more than $6.6b in ordinary shares. The filing includes shares tied to an employee stock ownership plan related offering. This shelf registration gives the company flexibility to issue shares in the future for potential corporate actions. For investors watching NasdaqGS:STX, the move comes with the stock trading at $407.25 with very large gains over the past year and past five years. The shares are also up 41.6% year to...

Pentair (PNR) shares are in focus after the company released its fourth quarter and full year 2025 results, introduced new 2026 guidance, and announced a reshaped leadership structure centered on technology, digital initiatives, and operational alignment. See our latest analysis for Pentair. Pentair’s share price has been under pressure in recent months, with a 90 day share price return of 9.26% decline and a year to date share price return of 6.49% decline. At the same time, its 3 year total...

If you are wondering whether Sarepta Therapeutics shares are now pricing in too much pessimism or hiding potential value, this article will walk through what the numbers are actually saying about the stock. The share price closed at US$18.33 recently, with returns of a 9.6% decline over 7 days, 23.1% decline over 30 days, 14.0% decline year to date, 83.3% decline over 1 year, 84.8% decline over 3 years and 79.8% decline over 5 years. These moves will naturally raise questions about risk and...

If you are wondering whether Citigroup shares still offer value after a strong run, this article walks through what the current price might be implying about the bank's long term prospects. The stock last closed at US$122.15, with returns of 3.8% over 7 days, 0.7% over 30 days, 2.9% year to date, 54.5% over 1 year and 127.0% over 5 years. This performance has many investors reassessing both upside potential and risk. Recent headlines around Citigroup have focused on its ongoing repositioning...

Teva Pharmaceutical Industries reported past full-year 2025 results showing sales rising to US$17.26 billion and a shift from a US$1.64 billion loss to US$1.41 billion in net income, alongside a return to positive earnings per share from continuing operations. This turnaround, helped by innovation-focused brands contributing around US$1 billion in quarterly revenue, has prompted analysts to reassess Teva’s earnings power and business mix. We’ll now examine how Teva’s move back to...

If you are wondering whether Sea's current share price reflects its true worth, you are not alone. Many investors are asking the same question as they reassess growth and risk in the stock. Sea's share price closed at US$113.33, with returns of 4.7% over the past week, a 15.1% decline over the past month, a 13.8% decline year to date, a 12.6% decline over the past year, a 76.4% gain over three years, and a 59.3% decline over five years. Recent coverage has focused on Sea's position as a...

In late January 2026, Clarivate Plc fully redeemed the remaining US$100 million of its 4.50% senior secured notes due 2026 using cash on hand, while also repurchasing about 56 million shares for US$225 million over 2025. The company also launched Clarivate Nexus, an AI-powered academic assistant aimed at helping students and researchers access trusted library content and discovery tools, underscoring its push to blend AI with its information services platform. We’ll now examine how...

United Therapeutics reported positive TETON-2 study results for inhaled treprostinil in idiopathic pulmonary fibrosis (IPF). The data indicate a potential role for inhaled treprostinil in helping stabilize lung function for IPF patients. The FDA qualified the PROLIFIC Risk Score, a tool designed to identify IPF patients at higher risk of rapid progression and support more targeted clinical trials. United Therapeutics (NasdaqGS:UTHR) is drawing attention as it pairs clinical momentum with a...

Recent trading in Customers Bancorp (CUBI) has drawn attention after a one-month return of about a 7% decline, alongside an 8.6% gain over the past 3 months, prompting fresh questions about valuation and earnings power. See our latest analysis for Customers Bancorp. At a share price of $73.14, Customers Bancorp has seen short term momentum ease, with a 7 day share price return of a 6.6% decline, while the 1 year total shareholder return of 25.9% and 5 year total shareholder return of 172.8%...

For readers wondering whether Mattel, at around US$21.06, is offering fair value right now or if the market is mispricing the toy maker, this article walks through what the numbers actually say about the stock. The share price is US$21.06 after a 0.6% decline over the last 7 days, a 2.0% decline over 30 days, a 5.1% gain year to date and a 3.6% decline over the past year. These moves give mixed signals when you compare them with its 13.5% and 12.9% annualized returns over 3 and 5...

Investors are watching Bright Horizons Family Solutions (BFAM) ahead of Thursday afternoon’s earnings, after the child care provider exceeded analyst expectations on revenue and adjusted earnings last quarter. The company enters this release with forecasts for slower, but still solid, year-on-year growth. See our latest analysis for Bright Horizons Family Solutions. At a share price of $85.04, Bright Horizons has seen a 17.0% 1 month share price return decline and a 14.4% year to date share...